Drug establishmentActive, Registered FY2026FDA warning letter on file

Dixon Investments Inc

Dixon Investments Inc is an FDA-registered drug establishment (FEI 1037559) located in Orchard Hill, Georgia. The facility is active, registered for FY2026. FDA has issued 1 warning letter(s) to this facility.

FDA warning letter

Sep 17, 2025

CGMP/Finished Pharmaceuticals/Adulterated

Read the letter on FDA.gov ›

A warning letter is FDA's formal notice of significant violations that require prompt correction. It can hold up product approvals, trigger import alerts, and put supply agreements at risk until the issues are resolved and FDA closes it out.

Establishment record

FEI Number

1037559

Address

2523 South McDonough Road, Orchard Hill, Georgia

Establishment type

Drug establishment

Products / operations

MANUFACTURE

Registration status

Active, Registered FY2026

Verify this record on FDA.gov ›

Inspection history

Inspections on file

None on file

Form 483 observations

None on file

FDA publishes only a subset of inspection records and Form 483s, so "None on file" is not a guarantee of a clean inspection history.

Questions

Is Dixon Investments Inc registered with the FDA?

Yes. Dixon Investments Inc is an FDA-registered drug establishment (FEI 1037559) in Orchard Hill, Georgia. Its current registration status is Active, Registered FY2026.

Has Dixon Investments Inc received an FDA warning letter?

Yes. FDA issued a warning letter to Dixon Investments Inc; the most recent is dated Sep 17, 2025 (CGMP/Finished Pharmaceuticals/Adulterated).

What does Dixon Investments Inc do?

Dixon Investments Inc's FDA-registered operations are: MANUFACTURE.

Related facilities

GUANGXI YULIN PHARMACEUTICAL GROUP CO LTD Liebel-Flarsheim Company LLC Acme United Corporation MERICON INDUSTRIES, INC.Scientific Protein Laboratories LLC Wisconsin Pharmacal Company, LLC

Source: FDA public data · status as of 2026-06-01